GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn Pharma Pharma giant GSK has sealed a $10bn deal to snap up Boston-based biopharmaceutical company Nuvalent. The FTSE 100 titan said it will pay $124 per share in cash in the agreement, marking a 40 per cent premium over what Nuvalent’s stock was trading at just before this announcement. The deal is expected to officially close [...]
Flush FTSE 100 giant Astrazeneca to give more back to shareholders with dividend hike pharma AstraZeneca will increase its annual dividend for the year by $0.20 (16p) to $3.10 (£2.47) per share
NHS pharmacy chain owed £40m before it was bought out of administration Administration An estimated £40m was owed by NHS pharmacy chain Medipharmacy before it collapsed into administration and was rescued, it has been revealed.